Expanding New Drugs for TB (endTB)

Posted on May 20, 2015

endTB is an innovative project using new TB drugs implemented by the international organizations Partners In Health (PIH), Médecins Sans Frontières (MSF), Interactive Research and Development (IRD), and funded by UNITAID with a four-year, 60.4 million USD grant. This poject aims to produce concrete results in the form of more effective and better-tolerated regimens for MDR-TB that will in turn lead to greater access.